Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Child's Nervous System
Published in: Child's Nervous System 10/2018

01-10-2018 | Special Annual Issue

Infections in the immunocompromised child

Authors: Llewellyn C. Padayachy, A. Graham Fieggen

Published in: Child's Nervous System | Issue 10/2018

Login to get access

Abstract

Prevention and management of opportunistic infections in children is particularly relevant in an era demonstrating an increased prevalence of immunocompromising conditions. The presence of an unusual organism which results in serious infection in a child should therefore always raise the consideration of immune compromise. The more common opportunistic infections have become easier to recognize in recent times due to improved awareness and more refined diagnostic testing. Targeted treatment is usually followed by long-term prophylactic medication. The impact of these conditions on patient outcome is of clear significance and certainly warrants further discussion.
Literature
1.
Algar V, Novelli V (2007) Infections in the immunocompromised host. Paediatr Child Health 17(4):132–136CrossRef
2.
Allen UD (2016) Management of infections in the immunocompromised child: general principles. LymphoSign J 3(3):87–98CrossRef
3.
Tulius M, Silva T, Grinsztejn B (2009) Opportunistic infections in the brain in developing countries. In: Paul RH et al. (eds) HIV and the brain, Current clinical neurology, pp 293–318
4.
Bonilla FA, Geha RS (2003) Primary immunodeficiency diseases. J Allergy Clin Immunol 111:S571–S581CrossRefPubMed
5.
Chinen J, Shearer WT (2010) Secondary immunodeficiencies including HIV infection. J Allergy Clin Immunol 125(2):S195–S203CrossRefPubMed
6.
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163(9):1009–1021CrossRefPubMed
7.
Kumar V, Abbas AK, Fausto N, Aster JC (2010) In: Robbins and Cotran pathologic basis of disease, 8th edn. Saunders Elsevier, Philadelphia
8.
Fieggen AG, Padayachy L (2015) Tuberculosis, parasitic and fungal infestations. In: Principles and practice of pediatric neurosurgery, 3rd edn. Thieme
9.
Thwaites GE, Lan NT, Dung NH et al (2005) Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 192(1):79–88CrossRefPubMed
10.
Figaji AA, Fieggen AG (2010) The neurosurgical and acute care management of tuberculous meningitis: evidence and current practice. Tuberculosis 90:393–400CrossRefPubMed
11.
Lammie GA, Hewlett RH, Schoeman JF, Donald PR (2009) Tuberculous cerebrovascular disease: a review. J Inf Secur 59:156–166
12.
13.
Wait JW, Schoeman JF (2009) Behaviour profiles after tuberculous meningitis. J Trop Pediatr 56(3):166–171CrossRefPubMed
14.
Chang L, Cornford ME, Chiang FL, Ernst TM, Sun NC, Miller BL (1995) Radiologic-pathologic correlation. Cerebral toxoplasmosis and lymphoma in AIDS. Am J Neuroradiol 16(8):1653–1663PubMed
15.
Andronikou S, Wieselthaler N, Smith B, Douis H, Fieggen AG, van Toorn R, Wilmshurst J (2005) Value of early follow-up CT in paediatric tuberculous meningitis. Pediatr Radiol 35:1092–1099CrossRefPubMed
16.
Idro R, Newton C (2005) Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 4:827–840CrossRefPubMed
17.
Tandon V, Mahapatra AK (2011) Management of post-tubercular hydrocephalus. Childs Nerv Syst 27:1699–1707CrossRefPubMed
18.
Rajshekhar V (2009) Management of hydrocephalus in patients with tuberculous meningitis. Neurol India 57(4):368–374CrossRefPubMed
19.
Bullock MRR, van Dellen JR (1982) The role of cerebrospinal fluid shunting in tuberculous meningitis. Surg Neurol 18:274–277CrossRefPubMed
20.
Lamprecht D, Schoeman J, Donald P, Hartzenberg H (2001) Ventriculoperitoneal shunting in childhood tuberculous meningitis. Br J Neurosurg 15(2):119–125CrossRefPubMed
21.
Sil K, Chatterjee S (2008) Shunting in tuberculous meningitis: a neurosurgeon’s nightmare. Childs Nerv Syst 24(9):1029–1032CrossRefPubMed
22.
Palur R, Rajshekar V, Chandy MJ, Joseph T, Abraham J (1991) Shunt surgery for hydrocephalus in tuberculous meningitis: a long-tem follow-up study. J Neurosurg 74:64–69CrossRefPubMed
23.
Figaji AA, Fieggen AG (2013) Endoscopic challenges and applications in tuberculous meningitis. World Neurosurg 79(2):S24–Se9CrossRefPubMed
24.
Singh P, Kochhar R, Vashishta RK, Khandelwal N, Prabhakar S, Mohindra S, Singhi P (2006) Amoebic meningoencephalitis: spectrum of imaging findings. Am J Neuroradiol 27(6):1217–1221PubMed
25.
Mathew JM, Rajshekar V, Chandy MJ (1998) Shunt surgery in poor grade patients with tuberculous meningitis and hydrocephalus: effects of response to external ventricular drainage and other variables on long-term outcome. J Neurol Neurosurg Psychiatry 65:115–118CrossRefPubMedPubMedCentral
26.
Peltzer K, Naidoo P, Matseke G, Louw J, Mchunu G, Tutshana B (2012) Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa. BMC Psychiatry 12(1):89CrossRefPubMedPubMedCentral
27.
Jonathan A, Rajshekhar V (2005) Endoscopic third ventriculostomy for chronic hydrocephalus after tuberculous meningitis. Surg Neurol 63:32–35CrossRefPubMed
28.
Janku J (1923) Pathogenesa a pathologicka anatomie tak nazveneho vrozeneho kolobomu slute skvrny v oku normalne velikem a mikrophthalmickem s nalezem parazitu v sitnici. Cas Lek Cesk 60:1021.20
29.
Grant A (1996) Varicella infection and toxoplasmosis in pregnancy. J Perinat Neonatal Nurs 10:17–29CrossRefPubMed
30.
Desmonts G, Couvreur J (1979) Congenital toxoplasmosis: a prospective study of the offspring of 54 women who acquired toxoplasmosis during pregnancy: pathophysiology of congenital disease. In: Thalhammer O, Baumgarten K, Pollak A (eds) Perinatal medicine. George Thieme, Stuttgart
31.
Arnold SJ, Kinney MC, McCormick MS, Dummer S, Scott MA (1997) Disseminated toxoplasmosis. Unusual presentations in the immunocompromised host. Arch Pathol Lab Med 121(8):869–873PubMed
32.
Conley FK, Jenkins HT, Remington JS (1981) Toxoplasma gondii infection of the central nervous system: use of peroxidise-antiperoxidase method to demonstrate toxoplasma in formalin fixed paraffin embedded tissue sections. Hum Pathol 12:690–698CrossRefPubMed
33.
Patel DV, Hofels E, Vogel N et al (1996) Resolution of intracerebral calcification in children with treated congenital toxoplasmosis. Radiology 199:433–440CrossRefPubMed
34.
Luft BJ, Conley F, Remington JS (1983) Outbreak of central nervous system toxoplasmosis in Western Europe and North America. Lancet 1:781–784CrossRefPubMed
35.
Diebler C, Dussler A, Dulac O (1985) Congenital toxoplasmosis: clinical and neuroradiological evaluation of the cerebral lesions. Neuroradiology 27:125–130CrossRefPubMed
36.
Remington JS, Mcleod R, Thuliez P et al (2006) Toxoplasmosis. In: Js R, Klein JO, Wilson CB et al (eds) Infectious diseases of the fetus and newborn, 6th edn. W.B. Saunders, Philadelphia, pp 947–1092CrossRef
37.
McCauley JB, Boyer KM, Remington JS, Mcleod RL (2009) Toxoplasmosis. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (eds) Textbook of pediatric infectious diseases, 6th edn. WB Saunders, Philadelphia, pp 2954–2971
38.
Desmonts G, Daffos F, Forrestier F et al (1985) Prenatal diagnosis of congenital toxoplasmosis. Lancet 1:500–504CrossRefPubMed
39.
Hohlfeld P, Daffos T, Costa JM et al (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain reaction test on amniotic fluid. N Engl J Med 331:695–699CrossRefPubMed
40.
Foulon W, Villena I, Stray-Pederson B et al (1999) Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year. Am J Obstet Gynecol 180:410–415CrossRefPubMed
41.
Wilson CB, Remington JS, Stagno S, Reynolds DW (1980) Development of adverse sequelae in children born with subclinical congenital toxoplasma infection. Pediatrics 66:767–774PubMed
42.
Roizen N, Swisher CN, Stein M, Hopkins J, Boyer KM, Holfels E, Mets MB, Stein L, Patel D, Meier P (1995) Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 95:11–20PubMed
43.
Mitchell CD, Erlich SS, Mastrucci MT, Hutto SC et al (1990) Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1. Pediatr Infect Dis J 9:512–518CrossRefPubMed
44.
Martinovic J, Sibalic D, Djordjevic M et al (1982) Frequency of toxoplasmosis in the appearance of congenital hydrocephalus. J Neurosurg 56:830–834CrossRefPubMed
45.
Stahl W, Kaneda Y (1997) Pathogenesis of murine toxoplasmic hydrocephalus. Parasitology 114:219–229CrossRefPubMed
46.
Porter SB, Sende MA (1992) Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.1992;327:1643–8
47.
Holliman RE (1988) Toxoplasmosis and the acquired immune deficiency syndrome. J Inf Secur 16:121–128
48.
Townsend JJ, Wolinsky JS, Baringer JR, Johnson PC (1975) Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol 32:335–343CrossRefPubMed
49.
Arendt G, von Giesen HJ, Hefter H, Neuen-Jacob E, Roick H, Jablonowski H (1999) Long-term course and outcome in AIDS patients with cerebral toxoplasmosis. Acta Neurol Scand 100:178–184CrossRefPubMed
50.
51.
Mitchell WG (1999) Neurocysticercosis and acquired cerebral toxoplasmosis in children. Semin Pediatr Neurol 6:267–277CrossRefPubMed
52.
Medina MT, DeGiorgio C (2002) Introduction to neurocysticercosis: a worldwide epidemic. Neurosurg Focus 12(6)
53.
Del Brutto OH, Santibanez R, Noboa CA et al (1992) Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 42:389–392CrossRefPubMed
54.
Carpio A, Escobar A, Hauser WA (1998) Cysticercosis and epilepsy: a critical review. Epilepsia 39:1025–1040CrossRefPubMed
55.
56.
Cao W, van der Ploeg CPB, Xu J et al (1997) Risk factor for human cysticercosis morbidity: a population based case-control study. Epidemiol Infect 119:231–235CrossRefPubMedPubMedCentral
57.
Sanchez AL, Lindback J, Schantz PM et al (1999) A population-based, case control study of Taenia solium taeniasis and cysicersosis. Ann Trop Med Parasitol 93(3):247–258CrossRefPubMed
58.
Schantz PM, Moore AC, Muńoz JL et al (1992) Neurocysticercosis in an orthodox Jewish community in New York City. NEJM 327:692–695CrossRefPubMed
59.
Pawlowski ZS (2002) Taenia solium: basic biology and transmission. In: Singh G, Prabhakar S (eds) Taenia solium cysticercosis. CABI Publishing, Wallingford, pp 1–23
60.
Escobar A (1983) The pathology of neurocysticercosis. In: Palcios E, Rodriguez-Carbajal, Taveras JM (eds) Cysticercosis of the central nervous system. Charles C. Thomas, Springfield, pp 27–54
61.
Sanz CR (1987) Host response in childhood neurocysticercosis: some pathological aspects. Childs Nerv Syst 3(4):206–207CrossRefPubMed
62.
Carpio A, Placencia M, Santillán F, Escobar A (1994) Proposal for a new classification of neurocysticercosis. Can J Neurol Sci 21:43–47CrossRefPubMed
63.
Estanol B, Corona T, Abad P (1986) A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 49:1131–1134CrossRefPubMedPubMedCentral
64.
65.
White AC (2000) Neurocysticercosis. Curr Treat Options Infect Dis 2:78–87
66.
67.
Schantz PM, Wilkins PP, Tsang VCW (1998) Immigrants, imaging, and immunoblots: the emergence of neurocysticercosis as a significant public health problem. In: Scheld WM, Craig WA, Hughes JM (eds) Emerging infections. ASM Press, Washington DC, pp 213–242CrossRef
68.
Jena A, Sanchatee PC, Gupta RK et al (1998) Cysticercosis of the brain shown by magnetic resonance imaging. Clin Radiol 39:542–546CrossRef
69.
Sinha S, Sharma BS (2009) Neurocysticercosis: a review of current status and management. J Clin Neurosci 16:867–876CrossRefPubMed
70.
Rajshekhar V (2003) Solitary cerebral cysticercus granuloma. Epilepsia 44(Suppl):25–28CrossRef
71.
Bittencourt PRM, Costa AJ, Oliveira TV, Gracia CM, Gorz AM, Mazer S (1990) Clinical, radiological and cerebrospinal fluid presentation of neurocysticercosis: a prospective study. Arq Neuropsiquiatr 48:286–289CrossRefPubMed
72.
Tsang VW, Brand JA, Boyer AE (1989) An enzyme-linked immunoelectrotransfer blot assay and glycoproteins antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 174:1007–1009
73.
St Geme JW III, Maldonado YA, Enzmann D et al (1993) Consensus: diagnosis and management of neurocysticercosis in children. Pediatr Infect Dis J 12:455–461CrossRefPubMed
74.
Garcia HH, Carlton A, Evans W, Nash TE et al (2002) Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 15(4):747–756CrossRefPubMedPubMedCentral
75.
Takayanagui OM, Jardim E (1992) Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 49:290–294CrossRefPubMed
76.
Sotelo J, Escobedo F, Panegos P (1988) Albendazole vs praziquantel therapy for neurocysticercosis. A controlled trial. Arch Neurol 45:532–534CrossRefPubMed
77.
Thornton CA, Houston S, Latif AS (1992) Neurocysticercosis and human immunodeficiency virus infection: a possible association. Arch Neurol 49:963–965CrossRefPubMed
78.
Woo E, Yu L, Huang CY (1988) Cerebral infarct precipitated by praziquantel in neurocysticercosis: a cautionary note. Trop Geogr Med 40:143–146PubMed
79.
Kelly R, Duong DH, Locke GE (2002) Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 50:757–762CrossRef
80.
Husain M, Jha DK, Rastogi M, Husain N, Gupta RK (2007) Neuro-endoscopic management of intraventricular neurocysticercosis (NCC). Acta Neurochir 149:341–346CrossRefPubMed
81.
Anandh B, Mohanty A, Sampath S, Praharaj SS, Kolluri S (2001) Endoscopic approach to intraventricular cysticercal lesions. Minim Invasive Neurosurg 44:194–196CrossRefPubMed
82.
Cavalheiro S, Zymberg ST, Teixera PD, Da Silva MC (2004) Hydrocephalus in neurocysticercosis and other parasitic and infectious diseases. In: Cinalli G, Maixner WJ, Saint-Rose C (eds) Pediatric hydrocephalus, vol 17. Springer-Verlag, Milan, pp 1–14
83.
Fowler M, Carter RF (1965) Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report. BMJ:740–742
84.
Anzil AP, Rao C, Wrzolek MA, Visvesvara GS, Sher JH, Kozlowski PB (1991) Amebic meningoencephalitis in a patient with AIDS caused by a newly recognised opportunistic pathogen, Leptomyxid ameba. Arch Pathol Lab Med 115:21–25PubMed
85.
Harms G, Feldmeier H (2005) The impact of HIV infection on tropical diseases. Infect Dis Clin N Am 19(1):121–135CrossRef
86.
87.
88.
Satishchandra P, Mathew T, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A, Shankar SK (2007) Cryptococcal meningitis: clinical, diagnostic and therapeutic overviews. Neurol India 55:226–232CrossRefPubMed
89.
Bruckner DA, Kokkinos HM (2009) Classification of fungi. In: Feigin and Cherry’s textbook of pediatric infectious diseases, vol 2. Saunders, Elsevier, pp 2715–2736
90.
Mohar A, Romo J, Salido F, Jessurun J, de León SP, Reyes E, Volkow P, Larraza O, Peredo MA, Cano C, Gomez G, Sepúlveda J, Mueller N (1992) The spectrum of clinical and pathological manifestation of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 6(5):467–473CrossRefPubMed
91.
Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC (2010) Practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50:291–322CrossRefPubMedPubMedCentral
92.
Baddley JW, Dismukes WE (2003) Cryptococcosis. In: Dismukes W, Pappas PG, Sobel JD (eds) Clinical mycology. Oxford University Press, New York, pp 188–205
93.
Couppie P, Aznar C, Carme B et al (2006) American Histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis 19(5):443–449CrossRefPubMed
94.
Ruhnke M, Grzegorz K, Otto K, Schwartz S (2007) CNS aspergillosis: recognition, diagnosis and management. CNS Drugs 21(8):659–676CrossRefPubMed
95.
Donabedian H, O’Donnell E, Olszzewski C et al (1994) Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis 18(2):111–115CrossRefPubMed
96.
97.
Potter M (2005) Strategies for managing systemic fungal infections and the place of itraconazole. J Antimicrob Chemother 56(Suppl 1):i49–i59CrossRefPubMed
98.
99.
Reuter JD, Gomez DL, Wilson JH, van den Pol AN (2004) Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain. J Virol 78:1473–1487CrossRefPubMedPubMedCentral
Metadata
Title
Infections in the immunocompromised child
Authors
Llewellyn C. Padayachy
A. Graham Fieggen
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 10/2018
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-018-3893-8

Other articles of this Issue 10/2018

Child's Nervous System 10/2018 Go to the issue

A.J. Raimondi ISPN Award

Pediatric neurosurgical bellwether procedures for infrastructure capacity building in hospitals and healthcare systems worldwide

Editorial

Special Annual Issue on CNS Infections

Special Annual Issue

The history of intracranial infections

Special Annual Issue

Pediatric spinal infections—a review of non-tuberculous infections

Special Annual Issue

Subdural empyema in children

Special Annual Issue

Prevention of healthcare-associated infections in paediatric intensive care unit